article thumbnail

New Diagnostic Blood Test For Alzheimer’s Disease Targets Tau

Forbes Healthcare

A newly published study from Sweden unveiled a blood test capable of detecting Alzheimer’s disease with 90% accuracy.

Tests 98
article thumbnail

Precision Diagnostics Can Save Money In Healthcare: What’s Holding Them Back?

Forbes Healthcare

But to accomplish this, the pricing and reimbursement model for diagnostic tests needs reform. Precision medicine allows for more efficient use of costly medicines.

article thumbnail

No More Invasive Tests: Hera Biotech’s Endometriosis Solution

Forbes Healthcare

Hera Biotech is developing a less invasive, more accurate diagnostic test for endometriosis, an often painful condition that can lead to infertility.

Tests 111
article thumbnail

Echocardiography as a Diagnostic Tool: How Cardiologists Use Echo to Assess Heart Health

Scrubs

Echocardiography, or echo for short, is a key diagnostic test used by cardiologists to assess the heart. In summary, echocardiography is an invaluable and versatile diagnostic technique. It utilizes high-frequency sound waves, also known as ultrasound, to generate images of the beating heart.

article thumbnail

The Rise of At-Home Health Diagnostics

Electronic Health Reporter

It’s been more than 35 years since the original at-home pregnancy tests came on the market. Since then, there has been a surge of home-testing options, driven by a fervid interest in wellness, expediency, cost-efficiency, […]. The article The Rise of At-Home Health Diagnostics appeared first on electronichealthreporter.com.

article thumbnail

Sepsis Causes Over 350,000 Deaths Annually. This Lab Test Can Reduce That By A Third.

Forbes Healthcare

Cytovale has developed a FDA-cleared, rapid diagnostic tool for sepsis, and it just raised $100 million to roll it out to hospital systems across the country.

Tests 144
article thumbnail

“Holy Grail” of Cancer Detection Can Predict Tumors Over a Year Before They Appear

Scrubs

A new cancer detection tool known as the “holy grail” of early detection is currently being tested in hospitals throughout the U.K., It is the first pan-cancer blood test, according to Ashish Tripathi, founder and CEO of Tzar Labs and chairman of Epigeneres Biotech, an Indian firm that first developed the test in 2021. “We

Tests 246